Patents

US10064840: A pharmaceutical composition for the treatment of multi-drug resistant infections

Filing Date: 06-03-2017

Issue Date: 04-09-2018

Applicant: CSIR – Indian Institute of Integrative Medicine (CSIR-IIIM), Jammu

Patent No: US10064840

Application No: 15/509183

Inventor(s): Vishwakarma Ram, Kumar Ajay, Khan Inshad Ali, Bharate Sandip Bibishan, Joshi Prashant, Singh Samsher, Satti Naresh

Country: United States of America

Related Patents

CN201280074294: A synergistic pharmaceutical composition useful for the treatment of lung cancer
CN3826268: A process for topotecan from 10-hydroxy-4-(s)-comptothecin
DE10394224: A process for the separation and recovery of polyethylene glycol (peg) spent aqueous two-phase system
DE1945354: Transesterification catalyst, process foer preparation thereof and a process for transesterification using the catalyst
DE2379175: Synthesis of hexadecyl c/s-9-tetradecenoate and hexadecyl c/s-10-tetradecenoate and their evaluation for anti arthritis properties in rats